MURAE Organisor is set to meet on February 13, 2024, to consider a stock split and bonus issue. The company achieved a 384.3% ...

Bain Capital has agreed to acquire Mitsubishi Chemical Group's pharmaceutical business for more than $3 billion, a deal that would allow the Japanese company to focus on its key chemical businesses.

Dan Rizzo, global head of Veeva Business Consulting, spoke with Pharmaceutical Executive about the state of product launches ...

Find insight on AstraZeneca, Eli Lilly, Siemens Healthineers and more in the latest Market Talks covering Health Care.

Japan’s Mitsubishi Chemical Group has resolved, at a meeting of the board of directors held today, to transfer its consolidated subsidiary, Mitsubishi Tanabe Pharma (MTPC), which engages in the ...

Shares in French cosmetics giant L'Oreal fell by more than 4% in early trade on Friday after the company posted its slowest ...

AbbVie, Danaher, Vertex Pharmaceuticals, Cencora, GSK, Thermo Fisher Scientific, and Moderna are the seven Biotech stocks to watch today, according to MarketBeat’s stock screener tool. Biotech stocks ...

CEO Jeff Tangney reported $169 million in revenue for Q3 2025, marking a 25% year-over-year growth and a 10% beat from the high end of guidance. Adjusted EBITDA margin reached 61%, with $102 million ...

Bausch Health Companies Inc.’s BHC share price has dipped by 10.90%, which has investors questioning if this is right time to buy.

The Trump Administration's 10% tariff on all Chinese imports took effect on Feb. 4. Many unknowns remain, but Americans will ...

President Donald Trump is facing pressure from U.S. hospitals and generic drugmakers to exempt medical goods from his new ...

It was manufactured by a well-known pharmaceutical company and may be used to treat a specific group of patients managing hypertension.